Free Trial

Synopsys, Inc. $SNPS Shares Sold by Robeco Schweiz AG

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Robeco Schweiz AG reduced its stake in Synopsys by 15.4% in Q4, selling 5,300 shares and retaining 29,200 shares worth about $13.716 million per its SEC filing.
  • Multiple large investors — including Vanguard, Victory Capital, Coatue, Capital Research and State Street — significantly increased or established positions, leaving institutional investors owning 85.47% of SNPS.
  • Synopsys reported quarterly EPS of $3.77 (beating estimates) and revenue of $2.41B (up 65.6% YoY), provided FY2026 EPS guidance of 14.38–14.46, and carries a consensus analyst rating of "Hold" with a $531 price target.
  • Interested in Synopsys? Here are five stocks we like better.

Robeco Schweiz AG lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 15.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,200 shares of the semiconductor company's stock after selling 5,300 shares during the period. Robeco Schweiz AG's holdings in Synopsys were worth $13,716,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in Synopsys by 20.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company's stock worth $8,970,415,000 after buying an additional 3,120,401 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Synopsys by 238.8% in the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company's stock worth $1,393,506,000 after buying an additional 1,990,608 shares during the last quarter. Coatue Management LLC acquired a new stake in Synopsys in the 3rd quarter worth about $892,605,000. Capital Research Global Investors boosted its stake in Synopsys by 226.6% in the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company's stock worth $1,245,533,000 after buying an additional 1,751,432 shares during the last quarter. Finally, State Street Corp boosted its stake in Synopsys by 20.6% in the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock worth $4,322,273,000 after buying an additional 1,493,912 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Performance

Shares of NASDAQ:SNPS opened at $504.42 on Thursday. The company has a market cap of $96.63 billion, a P/E ratio of 78.33, a PEG ratio of 4.11 and a beta of 1.25. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73. The business's 50-day simple moving average is $433.00 and its 200 day simple moving average is $446.63.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The company's revenue was up 65.6% on a year-over-year basis. During the same period last year, the business posted $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, sell-side analysts forecast that Synopsys, Inc. will post 10.3 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on SNPS shares. Weiss Ratings reissued a "hold (c)" rating on shares of Synopsys in a research note on Thursday, January 22nd. Rosenblatt Securities decreased their price target on Synopsys from $560.00 to $530.00 and set a "buy" rating on the stock in a research note on Thursday, February 26th. Piper Sandler decreased their price target on Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a research note on Thursday, February 26th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the stock a "buy" rating in a research note on Wednesday, February 25th. Finally, HSBC downgraded Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price objective on the stock. in a report on Friday, February 20th. Eight investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Synopsys currently has a consensus rating of "Hold" and a consensus price target of $531.00.

View Our Latest Stock Analysis on SNPS

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines